G. McDonald

发表

How I treat hepatitis C virus infection in patients with hematologic malignancies.

H. Torres, G. McDonald, 2016, Blood.

Cyclophosphamide metabolism is affected by azole antifungals.

W. Leisenring, M. Boeckh, L. Corey, 2004, Blood.

Intestinal and liver toxicity of antineoplastic drugs.

G. McDonald, N. Tirumali, 1984, The Western journal of medicine.

Esophageal infections in immunosuppressed patients after marrow transplantation.

Pankaj Sharma, R. Hackman, G. McDonald, 1985, Gastroenterology.

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

G. McDonald, L. DeLeve, H. Shulman, 2002, Seminars in liver disease.

National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.

M. Pulsipher, G. McDonald, M. Nieder, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

M. Turner, J. Wingard, Stephanie J. Lee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Portal venous transport of long-chain fatty acids absorbed from rat intestine.

G. McDonald, D. Saunders, M. Weidman, 1980, The American journal of physiology.

Partitioning of polar fatty acids into lymph and portal vein after intestinal absorption in the rat.

G. McDonald, M. Weidman, George B. McDonald, 1987, Quarterly journal of experimental physiology.

Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.

D. Blough, G. McDonald, J. McCune, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy.

G. McDonald, H. Shulman, E. Sievers, 2002, Blood.

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

K. Sullivan, R. Storb, G. Striker, 1980, The American journal of medicine.

Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.

H. Masur, J. Wingard, H. Torres, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis.

D. Jewell, D. Mason, K. Gatter, 1985, Human pathology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

H. Greinix, Stephanie J. Lee, M. Flowers, 2015 .

Gallstones in Pediatric Hematopoietic Cell Transplant Survivors With Up to 40 Years of Follow-up

B. Storer, G. McDonald, K. Baker, 2014, Journal of pediatric hematology/oncology.

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.

S. Grundy, A. Chait, J. Brunzell, 1983, Journal of lipid research.

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

M. Washington, Z. Argényi, A. Rashid, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction.

G. McDonald, M. Schwartz, 1987, JAMA.

Fibrosing Cholestatic Hepatitis C After Hematopoietic Cell Transplantation: Report of 3 Fatal Cases

K. Loeb, S. Hassan, D. Gretch, 2015, The American journal of surgical pathology.

Sinusoidal Obstruction Syndrome following CD 33-Targeted Therapy in Acute Myeloid Leukemia Running Title : SOS and CD 33-Targeted Therapy

R. Walter, G. McDonald, C. Godwin, 2017 .

Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.

R. Walter, G. McDonald, C. Godwin, 2017, Blood.

Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice

M. Tallman, G. McDonald, G. Graepel, 2013, International Journal of Hematology.

How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.

G. McDonald, 2016, Blood.

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

G. Anderson, G. McDonald, M. Mori, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.

K. Sullivan, J. Hannigan, R. Storb, 1990, Blood.

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, F. Appelbaum, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Venocclusive disease of the liver: prospective study of US evaluation.

C. Higano, G. McDonald, S. Teefey, 1992, Radiology.

Chronic graft‐versus‐host disease of the liver: Presentation as an acute hepatitis

M. Flowers, G. McDonald, S. Strasser, 2000, Hepatology.

Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients.

T. Kofler, T. Gooley, G. McDonald, 1995, Transplantation.

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

W. Leisenring, R. Hackman, G. McDonald, 1998, Medicine.

Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality.

Brian R. Phillips, T. Gooley, G. McDonald, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.

F. Appelbaum, C. Anasetti, G. McDonald, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

Pankaj Sharma, G. McDonald, E. Thomas, 1984, Hepatology.

Gastrointestinal, hepatobiliary, pancreatic, and iron-related diseases in long-term survivors of allogeneic hematopoietic cell transplantation.

G. McDonald, A. Kida, 2012, Seminars in hematology.

Review article: management of hepatic disease following haematopoietic cell transplant

G. McDonald, 2006, Alimentary pharmacology & therapeutics.

Gastrointestinal and Hepatic Complications of Solid Organ and Hematopoietic Cell Transplantation

A. Larson, G. McDonald, 2010 .

The fine structure of human rectal epithelium in acute graft‐versus‐host disease

G. McDonald, G. Sale, E. Thomas, 1982, The American journal of surgical pathology.

A simulation-based comparison of two methods for determining relaxation rates from relaxometry images.

Orpheus Kolokythas, S. Friedman, O. Kolokythas, 2011, Magnetic resonance imaging.

Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.

C. Alpers, K. Guthrie, G. McDonald, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

D. Jewell, G. McDonald, 1987, Journal of clinical pathology.

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. Pathology Working Group Report

M. Washington, Z. Argényi, A. Rashid, 2006 .

Metabolism‐based cyclophosphamide dosing for hematopoietic cell transplant

Brian R. Phillips, P. Vicini, G. McDonald, 2005, Clinical pharmacology and therapeutics.

Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant

B. Storer, W. Leisenring, G. McDonald, 2007, Bone Marrow Transplantation.

Specialty Conlerence Intestinal and Liver Toxicity of Antineoplastic Drugs

G. McDonald, Nigendra Tirumali, 2022 .

Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On

G. McDonald, 2010, Hepatology.

Graft-versus-host disease of the intestine

G. McDonald, G. Cox, 2004, Springer Seminars in Immunopathology.

Graft-versus-Host Disease of the Intestine and Liver

G. McDonald, 1988, Immunology and Allergy Clinics of North America.

The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patients

G. McDonald, G. Sale, E. Thomas, 1980 .

Gastrointestinal radiographic features of human graft-vs.-host disease.

J. Fisk, G. McDonald, G. Sale, 1981, AJR. American journal of roentgenology.

Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine.

G. McDonald, G. Tytgat, M. Kadin, 1985, Gastroenterology.

Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3+ T Cells

C. Higano, R. Hackman, G. Steinbach, 2010, Digestive Diseases and Sciences.

Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study.

J. Ostrow, G. Schoch, T. Gooley, 2016, The Lancet. Haematology.

Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.

S. Ziegler, B. Wood, D. Hockenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women.

A. Farrand, G. McDonald, G. Woelk, 1998, Journal of reproductive immunology.

Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease

J. Ziegler, C. Bell, T. Roscioli, 2006, Nature Genetics.

Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course.

B. Childs, G. McDonald, J. Fingeroth, 1994, Blood.

Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study.

G. Schoch, T. Gooley, G. McDonald, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Gastrointestinal graft‐versus‐host disease in man: A clinicopathologic study of the rectal biopsy

G. McDonald, G. Sale, E. Thomas, 1979, The American journal of surgical pathology.

Effect of ethanol on transport from rat intestine during high and low rates of oleate absorption

G. McDonald, D. Saunders, J. Sillery, 1982, Lipids.

Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.

D. Levine, D. Hockenbery, A. Farrand, 1998, Gastroenterology.

Crohn disease: remissions but no cure.

G. McDonald, R. Nash, 2010, Blood.

NCI, NHLBI First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Long Term Organ Damage and Dysfunction Following Pediatric Hematopoietic Cell Transplantation

G. McDonald, M. Nieder, S. Armenian, 2011 .

Esophageal infections: risk factors, presentation, diagnosis, and treatment.

G. McDonald, P. Baehr, 1994, Gastroenterology.

Esophageal Infections: Risk Factors, And Treatment

G. McDonald, P. Baehr, 1994 .

An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation.

K. Kopecky, G. McDonald, E. Thomas, 1980, Gastroenterology.

A novel soluble form of Tim-3 associated with severe graft-versus-host disease.

S. Hanash, B. Storer, Chee-Hong Wong, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver.

Gianni, P. Mannucci, G. McDonald, 1993, Blood.

Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Allen R. Chen, H. Uno, Lee-Jen Wei, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intestinal and hepatic complications of human bone marrow transplantation. Part II.

K. Sullivan, G. McDonald, H. Shulman, 1986, Gastroenterology.

Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite Carboxyethylphosphoramide mustard

P. Vicini, G. McDonald, J. Slattery, 2004, Clinical pharmacology and therapeutics.

Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy

M. Boeckh, D. Madtes, S. Pergam, 2016, Biology of Blood and Marrow Transplantation.

Etiology and Outcome of Diarrhea After Transplantation: A Prospective Study Marrow

R. Lo, R. Hackman, S. Matsui, 1994 .

Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review.

K. Guthrie, G. McDonald, H. Shulman, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatic Complications of Hematopoietic Cell Transplantation

G. McDonald, H. Shulman, 2007 .

Gastrointestinal and Hepatic Complications

G. McDonald, S. Strasser, 2007 .

Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10‐year follow‐up

K. Sullivan, B. Storer, M. Flowers, 1999, Hepatology.

Cirrhosis of the liver in long-term marrow transplant survivors.

K. Sullivan, B. Storer, G. McDonald, 1999, Blood.

Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation.

R. Ponec, R. Hackman, G. McDonald, 1999, Gastrointestinal endoscopy.

A coded histologic study of hepatic graft‐versus‐host disease after human bone marrow transplantation

Pankaj Sharma, G. McDonald, H. Shulman, 1988, Hepatology.

Management of hepatic sinusoidal obstruction syndrome following treatment with gemtuzumab ozogamicin (Mylotarg).

G. McDonald, 2002, Clinical lymphoma.

Supportive care.

J. Wingard, G. McDonald, W. Nichols, 2004, Hematology. American Society of Hematology. Education Program.

Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography

A. Paolicchi, G. McDonald, D. Campani, 2013, Bone Marrow Transplantation.

Intestinal metabolism and portal venous transport of 1,25(OH)2D3, 25(OH)D3, and vitamin D3 in the rat.

K. Lau, J. Wergedal, G. McDonald, 1985, The American journal of physiology.

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

M. Sorror, R. Storb, B. Sandmaier, 2020, Annals of Internal Medicine.

Oral beclomethasone dipropionate (BDP) for gastrointestinal GVHD: A corticosteroid-sparing treatment with improved survival at day +200

D. Hockenbery, G. McDonald, T. Rodell, 2006 .

Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

B. Storer, J. Hansen, G. McDonald, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of acute GVHD treatment outcomes 1 PREDICTIVE VALUE OF CLINICAL FINDINGS AND PLASMA BIOMARKERS AFTER 14 DAYS OF PREDNISONE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE

B. Storer, J. Hansen, G. McDonald, 2017 .

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.

B. Storer, J. Hansen, G. McDonald, 2015, Blood.

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.

R. Storb, B. Storer, F. Appelbaum, 2009, Blood.

Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation

R. Storb, B. Storer, F. Appelbaum, 2014, Bone Marrow Transplantation.

Graft‐Versus‐Host Disease

G. McDonald, 2012 .

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

R. Storb, B. Sandmaier, D. Maloney, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.

R. Storb, F. Appelbaum, G. Schoch, 1990, Blood.

Immunological Injury to the Intestine and Liver in Human Marrow Transplant Recipients

G. McDonald, 1989 .

Hepatic Vascular Pathology After Hematopoietic Cell Transplantation: Sinusoidal Obstruction Syndrome, Focal Nodular Hyperplasia, and Nodular Regenerative Hyperplasia

G. McDonald, 2011 .

Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms

G. McDonald, H. Shulman, H. Schoch, 1994, Hepatology.

Nutrient support in hematopoietic cell transplantation.

G. McDonald, B. Bruemmer, S. Aker, 2001, JPEN. Journal of parenteral and enteral nutrition.

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation.

T. Gooley, C. Anasetti, G. McDonald, 2003, Blood.

hematopoietic stem cell transplantation Cyclophosphamide metabolism , liver toxicity , and mortality following

T. Gooley, C. Anasetti, G. McDonald, 2002 .

Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning

M. Boyer, G. McDonald, G. Hildebrandt, 2015, International Journal of Hematology.

Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.

B. Storer, G. McDonald, J. McCune, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study

H. Deeg, F. Appelbaum, G. McDonald, 2003, Bone Marrow Transplantation.

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.

Allen R. Chen, Zhezhen Jin, P. Richardson, 2002, Blood.

Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation.

G. McDonald, W. Bensinger, H. Shulman, 2000, The American journal of surgical pathology.

Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced "hepatorenal syndrome".

J. Fink, G. McDonald, R. Zager, 1995, Journal of the American Society of Nephrology : JASN.

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

D. Shen, G. McDonald, S. Bearman, 1993, British journal of haematology.

Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation.

G. McDonald, M. Shuhart, S. Bearman, 1992, Blood.

A pilot study of low‐dose cyclosporin for graft‐versus‐host prophylaxis in marrow transplantation

M. Pepe, K. Sullivan, R. Storb, 1992, British journal of haematology.

Marrow transplantation in hepatitis‐associated aplastic anemia

K. Sullivan, R. Storb, F. Appelbaum, 1984, American journal of hematology.

Viral disease prevention after hematopoietic cell transplantation

H. Einsele, M. Boeckh, P. Ljungman, 2009, Bone Marrow Transplantation.

Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

G. McDonald, 2007, Expert opinion on investigational drugs.

Subconjunctival hemorrhage as a complication of endoscopy.

G. McDonald, P. Rajvanshi, 2001, Gastrointestinal endoscopy.

prednisone does not compromise patient outcomes Initial therapy of acute graft-versus-host disease with low-dose

R. Storb, B. Storer, F. Appelbaum, 2009 .

Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation

K. Guthrie, G. McDonald, J. McCune, 2008, The Pharmacogenomics Journal.

Esophageal abnormalities in chronic graft-versus-host disease in humans

K. Sullivan, G. McDonald, E. Thomas, 1981 .

A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.

F. Appelbaum, J. Bianco, J. Singer, 1993, Blood.

Diffuse intestinal ulceration after marrow transplantation: a clinicopathologic study of 13 patients.

G. McDonald, E. Thomas, H. Shulman, 1986, Human pathology.

Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation.

F. Appelbaum, G. McDonald, E. Thomas, 1987, Transplantation.

Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.

D. Hockenbery, T. Gooley, G. McDonald, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic kidney disease in long-term survivors of hematopoietic cell transplant

N. Weiss, G. Schoch, K. Guthrie, 2007, Bone Marrow Transplantation.

Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors.

G. Schoch, K. Guthrie, G. McDonald, 2005, Kidney international.

Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients

G. McDonald, H. Shulman, G B McDonald, 1993, Annals of Internal Medicine.

Liver Complications Following Treatment of Hematologic Malignancy With Anti‐CD22‐Calicheamicin (Inotuzumab Ozogamicin)

J. Freston, J. Boyer, G. McDonald, 2019, Hepatology.

Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation

G. McDonald, S. Hingorani, K. Seidel, 2015, Bone Marrow Transplantation.

allogeneic hematopoietic cell transplantation: a study of 193 patients Hepatic injury after nonmyeloablative conditioning followed by

M. Maris, R. Storb, B. Sandmaier, 2013 .

Severe Hepatocellular Injury After Hematopoietic Cell Transplant: Incidence, Etiology, and Outcome

G. McDonald, S. Strasser, H. Shulman, 2009, Bone Marrow Transplantation.

Liver disease of uncertain cause

G. McDonald, 2004, Bone Marrow Transplantation.

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.

H. Deeg, J. Radich, B. Storer, 2003, Blood.

Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome.

M. Thornquist, D. Hockenbery, G. McDonald, 2001 .

Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987–1997: incidence, causes, and outcome

M. Thornquist, D. Hockenbery, G. McDonald, 2001, American Journal of Gastroenterology.

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.

Jung Lim Lee, T. Gooley, G. McDonald, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management.

G. McDonald, S. Strasser, 1999, Blood.

Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.

K. Sullivan, R. Storb, B. Storer, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bleeding from gastric antral vascular ectasia in marrow transplant patients.

M. Kimmey, R. Hackman, G. McDonald, 1996, Gastrointestinal endoscopy.

Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients.

R. Ponec, S. Tzung, T. Brentnall, 1998, Transplantation.

Hepatitis C virus and allogeneic stem cell transplantation still matters!

G. McDonald, G. Socié, R. D. de Latour, 2009, Haematologica.

Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation.

M. Manns, K. Tsuneyama, A. Ahmed, 1999, Clinical immunology.

Liver Disease after Human Marrow Transplantation

G. McDonald, H. Shulman, J. Wolford, 1987, Seminars in liver disease.

A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation.

G. McDonald, S. Slichter, H. Shulman, 1990, Bone marrow transplantation.

Hepatic veno-occlusive disease following sirolimus-based immune suppression

J. Pidala, C. Anasetti, F. Locke, 2018, Bone Marrow Transplantation.

Hepatitis virus infections in patients with cancer

G. Lau, G. McDonald, S. Strasser, 2003 .

Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach

Brian R. Phillips, D. Salinger, P. Vicini, 2006, Clinical Cancer Research.

A problem-oriented approach to liver disease in oncology patients

G. McDonald, D. Frieze, George B. McDonald, 2008, Gut.

allogeneic hematopoietic stem cells Conditioning with fludarabine and targeted busulfan for transplantation of

J. Radich, B. Storer, F. Appelbaum, 2013 .

Response to Krejci and Mayer

G. McDonald, Paul J. Martin, P. Martin, 2010 .

Advances in prevention and treatment of hepatic disorders following hematopoietic cell transplantation.

G. McDonald, 2006, Best practice & research. Clinical haematology.

B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report

M. Turner, J. Wingard, Stephanie J. Lee, 2005 .

Cholestasis after hematopoietic cell transplantation.

G. McDonald, S. Strasser, H. Shulman, 1999, Clinics in liver disease.

Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors

K. Sullivan, R. Storb, F. Appelbaum, 1988 .

astrointestinal Graft-versus-Host Disease in ecipients of Autologous Hematopoietic Stem Cells: ncidence, Risk Factors, and Outcome

D. Hockenbery, T. Gooley, G. McDonald, 2006 .

Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation.

D. Hockenbery, R. Hackman, S. Tzung, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods.

R. Hackman, G. McDonald, J. Meyers, 1994, Transplantation.

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.

J. Radich, G. Schoch, J. Hansen, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic Graft versus Host Disease: Interdisciplinary Management: Gastrointestinal and Hepatic Manifestations of Chronic Graft versus Host Disease

G. McDonald, M. Sakai, 2009 .

Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale.

Meei-Li W Huang, G. McDonald, P. Carpenter, 2002, Blood.

ncreasingly Frequent Diagnosis of Acute astrointestinal Graft-versus-Host Disease after llogeneic Hematopoietic Cell Transplantation

R. Storb, F. Appelbaum, J. Hansen, 2004 .

Urinary elafin and kidney injury in hematopoietic cell transplant recipients.

B. Sandmaier, G. Schoch, T. Gooley, 2015, Clinical journal of the American Society of Nephrology : CJASN.

The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients.

G. McDonald, G. Sale, E. Thomas, 1980, Gastroenterology.

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon.

J. Ritz, R. Soiffer, G. McDonald, 1996, Transplantation.

Chemical composition of gallbladder sludge in patients after marrow transplantation.

G. McDonald, C. Ko, S. P. Lee, 1996, The American journal of gastroenterology.

Esophageal abnormalities in chronic graft-versus-host disease in humans.

K. Sullivan, G. McDonald, E. Thomas, 1981, Gastroenterology.

A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.

H. Deeg, K. Sullivan, J. Nims, 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation

G. McDonald, M. Shuhart, S. Bearman, 1992 .

Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.

G. McDonald, M. Sayers, D. Myerson, 1996, Bone marrow transplantation.

Hepatitis-associated aplastic anemia.

R. Storb, H. Kiem, G. McDonald, 1997, The New England journal of medicine.

National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.

J. Kurtzberg, S. Bhatia, C. Gracia, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Daniel Wolff, Yoshihiro Inamoto, Sandra A Mitchell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Michael Boeckh, Kieren A Marr, M. Sorror, 2010, The New England journal of medicine.

Ursodeoxycholic Acid Treatment of Refractory Chronic Graft-versus-Host Disease of the Liver

K. Sullivan, G. McDonald, R. Willson, 1992, Annals of Internal Medicine.

Hyperoxaluria correlates with fat malabsorption in patients with sprue.

G. McDonald, D. Earnest, W. Admirand, 1977, Gut.

Regional enteritis complicated by nephrocalcinosis and nephrolithiasis. Case report.

P. Chikos, G. McDonald, 1976, Radiology.

Regional differences in oxalate absorption by rat intestine: evidence for excessive absorption by the colon in steatorrhoea.

G. McDonald, D. Saunders, J. Sillery, 1975, Gut.

Intestinal and hepatic complications of human bone marrow transplantation. Part I.

K. Sullivan, G. McDonald, H. Shulman, 1986, Gastroenterology.

Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

K. Sullivan, R. Storb, G. McDonald, 1981, Blood.

Hepatobiliary Infections After Solid Organ or Hematopoietic Cell Transplantation

A. Larson, G. McDonald, 2016 .

Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial.

K. Kopecky, G. McDonald, E. Reed, 1990, Annals of internal medicine.

Cytomegalovirus hepatitis after bone marrow transplantation: An autopsy study with clinical, histologic and laboratory correlates

G. McDonald, D. Myerson, J. Sarmiento, 2019, Journal of viral hepatitis.

Gastrointestinal infections after solid organ or hematopoietic cell transplantation

C. Damman, G. McDonald, 2016 .

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: improved outcomes over two decades

P. Hari, M. Sorror, M. Maris, 2020, Haematologica.

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

R. Storb, B. Storer, M. Boeckh, 2015, Haematologica.

Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms

G. McDonald, M. Caballero, L. Vázquez, 2011, Bone Marrow Transplantation.

Radiographic features of esophageal involvement in chronic graft-vs.-host disease.

K. Sullivan, G. McDonald, T. Plumley, 1984, AJR. American journal of roentgenology.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Hirschfeld, Lynn H. Gerber, Sandra A. Mitchell, 2006 .

Prevention of hepatitis B virus transmission from an infected stem cell donor

J. Zaucha, G. McDonald, A. Piekarska, 2007, Bone Marrow Transplantation.

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

R. Storb, B. Sandmaier, D. Maloney, 2004, Blood.

Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients.

Jung Lim Lee, S. Bearman, G. McDonald, 1997, Blood.

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

H. Deeg, K. Sullivan, R. Storb, 1997, Blood.

Course of Crohn's disease after allogeneic marrow transplantation.

K. Sullivan, G. McDonald, S. O. Lopez-Cubero, 1998, Gastroenterology.

The risk of bleeding after percutaneous liver biopsy: relation to platelet count.

M. Banaji, G. McDonald, P. Sharma, 1982, Journal of clinical gastroenterology.

Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease

K. Loeb, D. Hockenbery, G. Steinbach, 2017, PloS one.

Sexually acquired amebic colitis and liver abscess.

G. McDonald, J. T. Ylvisaker, 1980, The Western journal of medicine.

Upper intestinal endoscopy induces hypoxemia in patients with obstructive pulmonary disease.

R. Albert, G. McDonald, P. Rostykus, 1978, Gastroenterology.

Pneumatosis cystoides intestinalis following allogeneic marrow transplantation.

H. Deeg, G. McDonald, E. Thomas, 1983, Transplantation proceedings.

transplantation regimen-related toxicities in patients undergoing allogeneic marrow A randomized controlled trial of pentoxifylline for the prevention of

J. Singer, G. McDonald, R. Bowden, 2011 .

Alive in continuous remission Alive after relapse Transplant deaths ’ Causes of Death Relapse Graft failure and infection Without GVHD CMV pneumonia Other infection Hemorrhage VOD of liver CMV pneumonia Other infection Pulmonary failure With chronic GVHD Infection CMV pneumonia

K. Sullivan, R. Storb, F. Appelbaum, 2003 .

A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation

F. Appelbaum, J. Bianco, J. Singer, 1993 .

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.

D. Hockenbery, T. Gooley, D. David, 2007, Blood.

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.

W. Leisenring, E. Petersdorf, G. McDonald, 2006, Blood.

Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients

F. Appelbaum, C. Anasetti, G. McDonald, 1998, Clinical pharmacology and therapeutics.

hematopoietic cell transplantation Risk factors for syngeneic graft-versus-host disease after adult

W. Leisenring, Jung Lim Lee, K. Guthrie, 2011 .

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation.

W. Leisenring, K. Guthrie, G. McDonald, 2004, Blood.

Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.

H. Deeg, K. Sullivan, R. Storb, 1996, Blood.

Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials

T. Gooley, G. McDonald, J. Chien, 2010, Bone Marrow Transplantation.

transmission rate and clinical course Marrow transplantation from hepatitis C virus seropositive donors

B. Childs, G. McDonald, D. Snyder, 2011 .

Retrograde esophagoscopy with a fiberoptic endoscope.

F. Silverstein, G. McDonald, 1977, Gastrointestinal endoscopy.

Systemic absorption of oral cholestyramine

G. McDonald, R. Vracko, 1984 .

The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.

D. Mozaffarian, G. McDonald, W. Levy, 2005, The American journal of cardiology.

Class IIantigen (HLA-DR)expression byintestinal epithelial cells ininflammatory diseases ofcolon

D. Jewell, G. McDonald, 1987 .

Infections of the Esophagus and Stomach

G. McDonald, 2012 .

Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.

R. Storb, W. Leisenring, F. Appelbaum, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation

T. Gooley, G. McDonald, H. Schoch, 2005, Hepatology.

disease: secondary treatment A retrospective analysis of therapy for acute graft-versus-host

R. Storb, G. Schoch, J. Hansen, 2011 .

Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients.

M. Pepe, C. Higano, F. Appelbaum, 1990, The American journal of medicine.

Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

H. Deeg, K. Sullivan, F. Appelbaum, 1996 .

Expanding the use of transjugular intrahepatic portosystemic shunts for veno‐occlusive disease

G. McDonald, P. Rajvanshi, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia

K. Sullivan, R. Storb, F. Appelbaum, 1989 .

Efficacy of neodymium:YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant

M. Kimmey, D. Hockenbery, G. Steinbach, 2006, Bone Marrow Transplantation.

Real-time DoseAdjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic CellTransplant : ABayesian Pharmacokinetic Approach

Brian R. Phillips, D. Salinger, D. Shen, 2006 .

Urinary Elaﬁn and Kidney Injury in Hematopoietic Cell Transplant Recipients

B. Sandmaier, G. Schoch, T. Gooley, 2014 .

Reduced Incidence of Acute and Chronic Graft-versus-Host Disease (GvHD) without Increased Relapse in Patients with High-Risk Myeloid Disorders Given Thymoglobulin (THY) as Part of the Transplant Conditioning Regimen: A Dose-Finding Study.

R. Storb, B. Storer, G. McDonald, 2004 .

Prognostic Factors And Outcomes Of Severe Gastrointestinal Graft-Vs-Host Disease (GI GVHD) After Allogeneic Hematopoietic Cell Transplantation

B. Storer, G. McDonald, R. Nash, 2009 .

regimens after hematopoietic cell transplantation with myeloablative conditioning An acute graft-versus-host disease activity index to predict survival

W. Leisenring, E. Petersdorf, G. McDonald, 2010 .

Risk factors for syngeneic graft-versus-host disease in adult hematopoietic stem cell transplants

W. Leisenring, K. Guthrie, G. McDonald, 2004 .

In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression.

D. Mozaffarian, J. Spertus, J. Russo, 2007, Journal of cardiac failure.

Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure.

D. Mozaffarian, C. Wilkinson, G. McDonald, 2005, The American journal of cardiology.

trans fatty acids and systemic inflammation in heart failure.

D. Mozaffarian, E. Rimm, G. McDonald, 2004, The American journal of clinical nutrition.

Acute necrotizing esophagitis.

G. McDonald, 1990, Gastroenterology.

ESOPHAGEAL INFECTIONS: RISK FACTORS, PRESENTATION, DIAGNOSIS AND TREATMENT

G. McDonald, P. Baehr, 1995 .

Pre-endoscopic use of oral simethicone.

G. McDonald, R. O’Leary, C. Stratton, 1978, Gastrointestinal endoscopy.

Multiple adenomatous neoplasms arising in columnarlined (Barrett's) esophagus.

G. McDonald, D. Thorning, D. Brand, 1977, Gastroenterology.

Can gastrointestinal endoscopy transmit hepatitis B to patients?

F. Silverstein, G. McDonald, 1976, Gastrointestinal endoscopy.

Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.

N. Weiss, L. Beretta, G. Ioannou, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.

G. McDonald, H. Shulman, H. Schoch, 1994, Hepatology.

Severe gastrointestinal bleeding after marrow transplantion, 1987–1997: Incidence, causes, and outcome

D. Hockenbery, G. McDonald, S. Strasser, 1998 .

Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation.

W. Leisenring, K. Marr, A. Upton, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients

M. Boeckh, D. Madtes, S. Pergam, 2013 .

A problem-oriented approach to intestinal and liver disease after marrow transplantation.

G. McDonald, J. Wolford, 1988, Journal of clinical gastroenterology.

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.

Zhezhen Jin, P. Richardson, E. Guinan, 2004 .

Prevalence of hepatitis G virus in patients with aplastic anemia.

R. Storb, W. Leisenring, H. Kiem, 1997, Blood.

Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.

H. Deeg, K. Sullivan, R. Storb, 1996, Biology of Blood and Marrow Transplantation.

The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation.

F. Appelbaum, J. Bianco, J. Singer, 1990, Transplantation.

Radionuclide venography.

W. Nelp, D. Strandness, T. Rudd, 1973, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cirrhosis of the liver in long-term marrow transplant survivors.

K. Sullivan, B. Storer, G. McDonald, 1999, Blood.

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial.

Zhezhen Jin, P. Richardson, E. Guinan, 2006 .

Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction.

G. McDonald, M. W. Schwartz, 1987, JAMA.

Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features.

R. Hackman, G. McDonald, G. Sale, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The post esophagectomy patient; An in-vivo disease model of Barrett's inflammation and tumorigenesis

J. Reynolds, O. Tucker, G. McDonald, 2003 .

Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis

R. Hackman, T. Gooley, G. McDonald, 1997, Bone Marrow Transplantation.

Acute Graft-Versus-Host Disease of the Esophagus

G. McDonald, G. Sale, S. Otero López-Cubero, 1997, Endoscopy.

Etiology and outcome of diarrhea after marrow transplantation: a prospective study.

R. Lo, R. Hackman, S. Matsui, 1994, Gastroenterology.

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy.

G. McDonald, H. Shulman, E. Sievers, 2002, Blood.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.

S. Ziegler, D. Hockenbery, R. Hackman, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bleomycin-detectable iron in plasma of bone-marrow transplant patients--its correlation with liver injury.

G. McDonald, R. Zager, C. Foerder, 1992, Transplantation.